This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Uniwersytet Jagielloński. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Iveta Kanepe-Lapsa: Innovator in Aromatic Sulphonamides Derivatives
Introduction
Iveta Kanepe-Lapsa is a prominent inventor based in Riga, Latvia. She has made significant contributions to the field of medicinal chemistry, particularly through her innovative work on aromatic sulphonamides derivatives. Her research focuses on developing compounds that can modulate the activity of protein disulfide isomerase (PDI), which has implications for various therapeutic applications.
Latest Patents
Iveta holds a patent for "Aromatic sulphonamides derivatives that inhibit PDI A3, their synthesis and use." This invention relates to a new group of aromatic sulphonamides derivatives that serve as small molecule inhibitors of PDI A3. These compounds exhibit antiplatelet, antithrombotic, and anticancer activities, showcasing their potential in treating serious health conditions. She has 1 patent to her name, reflecting her innovative contributions to the field.
Career Highlights
Iveta is affiliated with Jagiellonian University, where she continues her research and development efforts. Her work has garnered attention for its potential impact on therapeutic strategies, particularly in the areas of cancer treatment and cardiovascular health.
Collaborations
Iveta collaborates with esteemed colleagues, including Stefan Chlopicki and Ivars Kalvins. These partnerships enhance her research capabilities and contribute to the advancement of her innovative projects.
Conclusion
Iveta Kanepe-Lapsa is a trailblazer in the field of medicinal chemistry, with her work on aromatic sulphonamides derivatives paving the way for new therapeutic options. Her dedication to innovation and collaboration underscores her significant role in advancing medical science.